Hadeesha completed his Ph.D. at the University of Manitoba (Dr. Neeloffer Mookherjee’s lab) where he used animal models and multi-omic approaches to study the use of synthetic immunoregulatory peptides in airway inflammation. For his postdoc at the Angelo and Bendall lab, he is leveraging MIBI to generate a comprehensive understanding of the TME and the antigenic heterogeneity of glial tumors from pediatric and adult patients in response to the conventional, vaccine, a checkpoint inhibitor, and cellular therapies.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)